Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2000-10-20
2003-10-14
Falk, Anne-Marie (Department: 1636)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
Reexamination Certificate
active
06632978
ABSTRACT:
BACKGROUND OF THE INVENTION
Vascular endothelial cell (EC) activation is one of the first events in inflammatory conditions and transplant rejection. A specific marker of EC activation is E-selectin. Expression of this gene is generally absent under resting conditions and induced by inflammatory stimuli, as well as being NF-kB dependent. Expression is restricted to the endothelium.
Immunohistochemistry is a standard technique by which signalling events involved in disorders associated with inflammatory, thrombotic, ischaemic or neoplastic conditions or transplant rejection, can be assessed; and, for example, E-selectin expression can be readily studied by this method in vitro. However, monitoring of E-selectin expression in vivo has been limited to immunohistochemistry of biopsies or post-mortem specimens. There has been a need by workers in the art for an in vivo model allowing assessment of E-selectin expression in a live subject.
SUMMARY OF THE INVENTION
The present invention relates to an animal model useful for screening potential therapeutic agents for the treatment of disorders associated with inflammatory, thrombotic, ischaemic or neoplastic conditions or prevention of transplant rejection. In particular, the present invention provides a novel model in which endothelial cell activation can be assessed in vivo by a simple and sensitive enzyme assay.
REFERENCES:
patent: 5151508 (1992-09-01), Salbaum et al.
patent: 6217847 (2001-04-01), Contag et al.
patent: WO 99/43783 (1999-09-01), None
Yang et al., Quantification of gene expression with a secreted alkaline phosphatase reporter system, 1997, Biotechniques, vol. 23, pp. 1110-1114.*
Campbell et al., Totipotency or multipotentiality of cultured cells: Applications and Progress, 1997, Theriogenology, vol. 47, pp. 63-72.*
Bradley et al., Modifying the mouse: design and desire, 1992, Bio/Technology, vol. 10, pp. 534-539.*
Sigmund, Viewpoint: Are studies in genetically altered mice out of control?, 2000, Arterioscler Thromb. Vasc. Biol., vol. 20, pp. 1425-1429.*
Wall, Transgenic livestock: Progress and prospects for the future, 1996, Theriogenology, vol. 45, pp. 57-68.*
Carlsen et al., Keystone Symposium, NF-&kgr;B Regulation and Function: From Basic Research to Drug Development, Tahoe City Feb. 22-27, Abstract 205 (2000).
Zerwes et al., Keystone Symposium, NF&kgr;B Regulation and Function: From Basic Research to Drug Development, Tahoe City Feb. 22-27, Abstract 261 and Poster (2000).
Ray K.P. et al., Biochem. J., vol. 328, pp. 707-715 (1997).
Gupta M.P. et al., Molecular and Cellular Biochemistry, vol. 157, pp. 117-124 (1996).
Ogg, M.S. et al., Xenobiotica, vol. 29, No. 3, pp. 269-279 (1999).
Käslin Edgar
Luyten Marcel
Zerwes Hans-Günter
Falk Anne-Marie
Novartis AG
Qian Celine
Savitsky Thomas R.
LandOfFree
Transgenic animals for studying regulation of genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic animals for studying regulation of genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic animals for studying regulation of genes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3134133